IP Library Granted Patent US 10,174,059
Granted Patent B2
US 10,174,059 · App. 15/065,289 · Granted Jan 8, 2019

Functionalized F-POSS monomer compositions and uses thereof

Inventors: John C. Warner (Wilmington, MA); Jean R. Loebelenz (Essex, MA); Srinivasa Rao Cheruku (Lexington, MA); Thomas Woodrow Gero (Stow, MA)
Assignee: NBD NANOTECHNOLOGIES, INC.
C07F7/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,174,059
App. No.
15/065,289
Granted
Jan 8, 2019
Kind
B2
Abstract

Functionalized F-POSS compounds comprising synthetic blends of at least two feedstocks that produce a distribution of fluorinated polyhedral oligomeric silsesquioxane molecule structures and/or functional groups.

Claims (42)

1. A compound having the formula:

wherein,

R 1 is a long chain fluorinated alkyl having from 5 to 12 carbon atoms;

R 2 is propyl substituted by an R 3 ;

R 3 is —OC(O)OR 4 ;

R 4 is selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 3-7 membered heterocyclic, and 5-7 membered heteroaryl, wherein each hydrogen atom in R 4 and R 5 is independently optionally substituted by an R 6 ;

each R 6 is independently selected from the group consisting of halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 3-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 7 , —NR 7 R 8 , —C(O)OR 7 ,—C(O)R 7 , —OC(O)OR 7 , —C(O)NR 7 R 8 , —OC(O)NR 7 R 8 , —NR 7 C(O)R 8 , —NR 7 C(O)OR 8 and —NR 7 C(O)NR 7 R 8 , and when R 6 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic or 5-7 membered heteroaryl, each hydrogen atom in R 6 is independently optionally substituted by an R 9 ;

each R 7 and R 8 is independently selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic and 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 and R 8 is independently optionally substituted by one or more R 9 ;

each R 9 is independently selected from the group consisting of hydrogen, halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 10 , —NR 10 R 11 , —OC(O)R 10 , —C(O)OR 10 , —C(O)R 10 , —OC(O)OR 10 , —C(O)NR 10 R 11 , —OC(O)NR 10 R 11 , —NR 10 C(O)R 11 , —NR 10 C(O)OR 11 and —NR 10 C(O)NR 10 R 11 , and when R 9 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, C 3 -C 8 cycloalkyl or 5-7 membered heteroaryl, each hydrogen in R 9 is independently optionally substituted by a moiety selected from the group consisting of halo, —NCO, —OR 10 , —NR 10 R 11 , —C(O)OR 10 , —C(O)R 10 , —OC(O)OR 10 , —C(O)NR 10 R 11 , —OC(O)NR 10 R 11 , —NR 10 C(O)R 11 , —NR 10 C(O)OR 11 and —NR 10 C(O)NR 10 R 11 ;

each R 10 and R 11 is independently selected from the group consisting of H, C 1 -C 8 alkyl, C 2 -C 8 alkenyl and C 2 -C 8 alkynyl, and when R 10 or R 11 are either C 1 -C 8 alkyl, C 2 -C 8 alkenyl or C 2 -C 8 alkynyl, each hydrogen atom in R 10 and R 11 is independently optionally substituted by a fluorine atom;

n is an integer from 1 to 7; and,

each R 1 and R 2 is independently covalently attached at a silicon atom.

2. The compound of claim 1 , wherein R 4 is C 1 -C 8 alkyl and wherein each hydrogen atom in R 4 is independently optionally substituted by an R 6 .

3. The compound of claim 2 , wherein R 6 is either C 1 -C 8 alkyl, —NCO, —OR 7 , —NR 7 R 8 , —OC(O)R 7 , —C(O)OR 7 , —C(O)R 7 or —OC(O)OR 7 .

4. The compound of claim 3 , wherein R 7 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl or 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 is independently optionally substituted by one or more R 9 .

5. The compound of claim 2 , wherein R 6 is either C 1 -C 8 alkyl, —NCO, -OR 7 , —NR 7 R 8 ,—OC(O)R 7 , —C(O)OR 7 , —C(O)R 7 or —OC(O)OR 7 .

6. The compound of claim 1 , R 4 is C 2 -C 8 alkenyl, wherein each hydrogen atom in R 4 is independently optionally substituted by an R 6 .

7. The compound of claim 6 , wherein R 6 is either C 1 -C 8 alkyl, —NCO, —OR 7 , —NR 7 R 8 , —OC(O)R 7 , —C(O)OR 7 , —C(O)R 7 or —OC(O)OR 7 .

8. The compound of claim 7 , wherein R 7 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl or 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 is independently optionally substituted by one or more R 9 .

9. The compound of claim 1 , wherein R 6 is either C 1 -C 8 alkyl, —NCO, —OR 7 , —NR 7 R 8 , —OC(O)R 7 , —C(O)OR 7 , —C(O)R 7 or —OC(O)OR 7 .

10. The compound of claim 1 , wherein R 7 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl or 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 is independently optionally substituted by one or more R 9 .

11. The compound of claim 1 , wherein R 9 is either hydrogen or C 1 -C 8 alkyl, and when R 9 is C 1 -C 8 alkyl, R 9 is optionally substituted by a —OC(O)R 10 .

12. The compound of claim 1 , wherein R 10 is either H or C 1 -C 8 alkyl, and when R 10 is C 1 -C 8 alkyl, each hydrogen atom in R 10 is independently optionally substituted by a fluorine atom.

13. The compound claim 1 , wherein the long chain fluorinated alkyl is either 8/2, 6/2 or 4/2.

14. A compound having the formula:

wherein,

R 1 is a long chain fluorinated alkyl having from 5 to 12 carbon atoms;

R 2 is propyl, wherein each hydrogen atom is independently optionally substituted by an R 3 ;

each R 3 is selected from the group consisting of halo, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 3-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 4 , —NR 4 R 5 , —C(O)OR 4 , —C(O)R 4 , —OC(O)OR 4 , —C(O)NR 4 R 5 , —OC(O)NR 4 R 5 , —NR 4 C(O)R 5 , —NR 4 C(O)OR 5 and —NR 4 C(O)NR 4 R 5 , and when R 3 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic or 5-7 membered heteroaryl, each hydrogen atom in R 3 is independently optionally substituted by an R 6 ;

R 4 is —CH═CH 2 , wherein each hydrogen atom in R 4 is independently optionally substituted by methyl;

each R 6 is independently selected from the group consisting of halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 3-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 7 , —NR 7 R 8 , —C(O)OR 7 , —C(O)R 7 , —OC(O)OR 7 , —C(O)NR 7 R 8 , —OC(O)NR 7 R 8 , —NR 7 C(O)R 8 , —NR 7 C(O)OR 8 and —NR 7 C(O)NR 7 R 8 , and when R 6 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic or 5-7 membered heteroaryl, each hydrogen atom in R 6 is independently optionally substituted by an R 9 ;

each R 7 and R 8 is independently selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic and 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 and R 8 is independently optionally substituted by one or more R 9 ;

each R 9 is independently selected from the group consisting of hydrogen, halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 10 , —NR 10 R 11 , —OC(O)R 10 , —C(O)OR 10 , —C(O)R 10 , —OC(O)OR 10 , —C(O)NR 10 R 11 , —OC(O)NR 10 R 11 , —NR 10 C(O)R 11 , —NR 10 C(O)OR 11 and —NR 10 C(O)NR 10 R 11 , and when R 9 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, C 3 -C 8 cycloalkyl or 5-7 membered heteroaryl, each hydrogen in R 9 is independently optionally substituted by a moiety selected from the group consisting of halo, —NCO, —OR 10 , —NR 10 R 11 , —C(O)OR 10 , —C(O)R 10 , —OC(O)OR 10 , —C(O)NR 10 R 11 , —OC(O)NR 10 R 11 , —NR 10 C(O)R 11 , —NR 10 C(O)OR 11 and —NR 10 C(O)NR 10 R 11 ;

each R 10 and R 11 is independently selected from the group consisting of H, C 1 -C 8 alkyl, C 2 -C 8 alkenyl and C 2 -C 8 alkynyl, and when R 10 or R 11 are either C 1 -C 8 alkyl, C 2 -C 8 alkenyl or C 2 -C 8 alkynyl, each hydrogen atom in R 10 and R 11 is independently optionally substituted by a fluorine atom;

n is an integer from 1 to 6; and,

each R 1 and R 2 is independently covalently attached at a silicon atom.

15. The compound of claim 14 , wherein R 3 is either —NCO, —OR 4 , —OC(O)R 4 , —C(O)OR 4 , —C(O)R 4 or —OC(O)OR 4 .

16. The compound of claim 14 , wherein R 6 is either C 1 -C 8 alkyl, —NCO, —OR 7 , —NR 7 R 8 , —OC(O)R 7 , —C(O)OR 7 , —C(O)R 7 or —OC(O)OR 7 .

17. The compound of claim 14 , wherein R 7 is either C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl or 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 is independently optionally substituted by one or more R 9 .

18. The compound of claim 14 , wherein R 9 is either hydrogen or C 1 -C 8 alkyl, and when R 9 is C 1 -C 8 alkyl, R 9 is optionally substituted by a —OC(O)R 10 .

19. The compound of claim 14 , wherein R 10 is either H or C 1 -C 8 alkyl, and when R 10 is C 1 -C 8 alkyl, each hydrogen atom in R 10 is independently optionally substituted by a fluorine atom.

20. The compound claim 14 , wherein the long chain fluorinated alkyl is either 8/2, 6/2 or 4/2.

Assignments (3)
CORRECTIVE ASSIGNMENT TO REMOVE U.S. PATENT NOS. 10,525,504 AND U.S. PATENT APPLICATION NO. 14/268,757 PREVIOUSLY RECORDED AT REEL: 065406 FRAME: 0320. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 13, 2025
From: NBD NANOTECHNOLOGIES INC.
To: HENKEL AG & CO. KGAA
Reel/Frame 070510/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2023
From: NBD NANOTECHNOLOGIES INC.
To: HENKEL AG & CO. KGAA
Reel/Frame 065406/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2018
From: WARNER, JOHN CHARLES; LOEBELENZ, JEAN R.; CHERUKU, SRINIVASA RAO; GERO, THOMAS WOODROW
To: NBD NANOTECHNOLOGIES, INC.
Reel/Frame 047515/0561 →
Continuity (2)
Provisional Application 62130170 · Mar 9, 2015
Related Publication 20160264599A1 · Sep 15, 2016
Cited By (1)
US 12,672,476